Avenacy releases magnesium sulfate in water for injection
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, is introducing magnesium sulfate in water for injection.
Magnesium sulfate in water for injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia.
"When used judiciously, it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose," Avenacy said.
Avenacy's magnesium sulfate in water for injection is available in ready-to-use premix IV bags in multiple formulations: 2g/50ml (40mg/ml), 4g/100ml (40mg/ml) and 4g/50ml (80mg/ml).
Magnesium sulfate in water for injection will feature the company’s packaging and labeling to support accurate medication selection. Additionally, the ready-to-use presentation is expected to help reduce dosing inaccuracies, enhance patient safety and streamline inventory, the company said.
[Read more: Generic sterile injectables market to reach $196.2B by 2029]
“As a vital product for healthcare providers, magnesium sulfate represents a large market opportunity for Avenacy, and we are excited to deliver this ready-to-use product to hospitals all over the country as a means to improve patient care,” said Jeff Yordon, co-founder and CEO of Avenacy. “Since launching seven months ago, we have seen very encouraging early traction of Avenacy’s products in the market, and we are proud to be launching our eighth product as we continue to scale up our business in order to meet demand for our injectable medications.”
Avenacy will partner with Milla Pharmaceuticals, the U.S. subsidiary of global generic and pharmacy service player A.forall, to begin shipping magnesium sulfate in water for Injection to wholesale partners this week. Milla Pharmaceuticals is part of Avenacy’s global network of development and contract manufacturing partners that have undergone successful FDA inspections based on cGMP standards.
“We're excited to work with Avenacy to introduce magnesium sulfate in water for injection to the market,” said Erik Lazarich, president of A.forall’s U.S. operations, “Delivering this ready-to-use product to hospitals nationwide is a key step in improving patient care and advancing our mission of making affordable medicines available to all.”
[Read more: Avenacy launches 2 new generics]
Magnesium sulfate in water for injection had a market value of approximately $37 million for the 12 months ending in June 2023, per IQVIA.